Shanghai Medicilon Vice-President of Biology, Dr. Jun Wang was invited to present his research on“The Development and mechanisms of Platensimycin and Platencin”. Also invited to the presentation is Dr. Mei Ge of Shanghai Health Creation Bio-Pharmaceutical R&D Center. Detailed information on the presentation is as follows:

Time: December 27th (Tuesday) 2:00 PM

Location: College of Pharmacology, Building #5, Room 312

Presenter: Dr. Jun Wang

Title: “The Development and mechanisms of Platensimycin and Platencin”

Background of Presenter:

Dr. Jun Wang, VP of Discovery Bioloigy at Shanghai Medicilon.Inc., before joining Medicilon, Dr.Wang was VP and Head of Biology at Sundia MediTech. Dr. Wang served at Merck&Co., Inc. for 9 years leading multiple drug-discovery programs on principles of food-animal growth promotion, infectious diseases, diabetics and cardiovascular diseases. Prior to Merck, Dr. Wang worked at a biotech company in Seattle as the head of biology section and served as an assistant professor in University of Texas Southwestern Medical Center and University of Washington for 5 years. Dr. Wang has been invited by many corresponding author in leading scientific journals. Lately, Dr. Wang has been invited by many organizations including University of Cambridge, Royal Society of Chemistry, Naito Foundation etc. for presentations on his discovery of novel candidates of antibiotics (Platensimycin and Platencin). Dr. Wang got his BS in biophysics from Fudan University and received his Ph.D. in molecular biology and biochemistry from Kobe University (Japan). Post-doc training was followed in the Department of Pharmacology at UT Southwestern Medical Center (Dallas).